Empyrean Capital Partners’s Qiagen QGEN Stock Holding History

Empyrean Capital Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-259,564	Closed	-$11.4M	–	75
2020 Q1	$11.4M	Buy	+259,564	New	+$10.1M	0.79%	30

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empyrean Capital Partners's QGEN Position: Q2 2020 in Review

Empyrean Capital Partners sold out of Qiagen (QGEN) in Q2 2020, closing a stake of 259,564 shares — an estimated $11.4M sold.

Empyrean Capital Partners first reported a position in QGEN in Q1 2020 and held it in 1 quarter. The position peaked at $11.4M in Q1 2020. 275 funds tracked by Wall St. Rank hold QGEN as of Q2 2020.

Empyrean Capital Partners reported no remaining Qiagen position as of Q2 2020 after selling out during the quarter.
Empyrean Capital Partners sold 259,564 Qiagen shares in Q2 2020, an estimated $11.4M.
Empyrean Capital Partners first reported a position in Qiagen in Q1 2020 and held it in 1 quarter.
Empyrean Capital Partners's Qiagen position peaked at $11.4M in Q1 2020.
275 funds tracked by Wall St. Rank held Qiagen as of Q2 2020.

Based on Empyrean Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.